Acamprosate (Campral): What It Is

Acamprosate, sold under the brand name Campral, is one of three medications the FDA has approved for alcohol use disorder; the other two are disulfiram and naltrexone. What sets acamprosate apart is not how strong it is but where in the process it is meant to act: it is studied as a way to help people who have already stopped drinking stay stopped.

Where it acts in the brain

Alcohol quiets the brain's main "go" signals and leans on its "calm down" ones. Do that heavily for months or years and the brain resets itself around the constant tilt. Take the alcohol away and that reset is still there, so the two sides no longer line up — which is part of why early sobriety can feel so restless and raw.

In the pharmacology literature, acamprosate is described as working on that over-revved "go" system — the one alcohol had been leaning on for years — to help it settle back toward normal. That is also why it is FDA-approved to help people stay stopped once they have already quit, rather than to help someone cut down while still drinking.

The three approved medicines are not three versions of the same promise. As one peer-reviewed overview lays out, they do genuinely different jobs. Disulfiram makes your body react badly to alcohol, so drinking on it makes you feel ill — it works like a tripwire. Naltrexone turns down the pleasant lift a drink gives you, so drinking feels less worth it. Acamprosate leaves that reward alone and instead works on the restless, off-balance feeling that can linger for months after you stop. Three different tools, three different jobs.

One clear limit: acamprosate is not a medicine for getting through withdrawal, and it is not a first step for someone still drinking every day. If that is you, the safety question — how to stop safely — comes before any long-term-medication question. Start with understanding alcohol withdrawal symptoms and treatment options.

What the evidence frames, and what it leaves open

Acamprosate appears on every authoritative list of FDA-approved AUD options. The American Academy of Family Physicians groups it with naltrexone among the better-supported approved medications and recommends pairing any medication with behavioral support rather than using it alone. That tells you acamprosate is a real, mainstream option. Whether it is the right one for you is an individual question the evidence cannot answer in the abstract.

The evidence lists options; it does not match one to you. And here is the part worth sitting with: the same body of work that calls acamprosate well-supported also shows that most people with alcohol use disorder are never offered any medication at all. That is not a sign the medicines don't work. It is mostly that the conversation never happens — people never see a clinician who raises it, or never reach the point of asking. Clero's role is deliberately narrow: make the medication question easier to bring to a clinician, without letting an article decide the answer.

In 2024, an estimated 27.9 million people ages 12 and older in the United States had past-year alcohol use disorder — about 9.7% of that age group, per NIAAA. In the same year, roughly 2.1 million of them received any alcohol-use treatment: about 7.6% of people with past-year AUD. The number receiving an FDA-approved medication is smaller still. So if you are reading about acamprosate at all, you are already doing something most people in your position never get the chance to do.

That gap matters because medication questions often carry shame — if I need medication, is my problem worse than I thought? The figures say the opposite of what the shame implies: asking is the uncommon part, not the failing part.

What this looks like in practice

A few concrete reframes, each for a different starting point:

• If your goal is to cut down, not stop, say that first. Acamprosate is built around staying off alcohol after you quit, so a moderation goal may point toward a different conversation entirely. Naming the goal plainly lets a clinician match the option to it instead of the other way around.
• Describe the drinking in plain numbers. A U.S. standard drink is 0.6 fluid ounces, or 14 grams, of pure alcohol, and NIAAA counts binge drinking as the pattern that brings blood alcohol to about 0.08% — often 5 or more drinks for men, or 4 or more for women, in about two hours. These are just shared ways to describe a pattern, not a line where harm switches on. A clinician weighing whether a stay-stopped medicine fits needs an honest picture of how much you actually drink, so a real number helps more than a vague one.
• Treat "which medication is better" as the wrong question. A sharper one is: given my goal and history, which option is worth discussing first? If one medication doesn't fit, that is not the end of care — goals, side effects, and support all change, and the next conversation can change with them.

Bringing it to a clinician

A clinician deciding about acamprosate will usually ask about your current drinking, whether you have already stopped, how your kidneys are working, other medications, mental health, past withdrawal, and support at home. Kidneys are on that list for a specific reason: acamprosate leaves the body through the kidneys instead of being processed by the liver, which is part of why it comes up for people whose liver is already strained by heavy drinking. The safety literature generally describes it as easy to tolerate, with an upset stomach — loose stools most often — being the usual complaint. These questions are simply how a medication decision gets made safely.

For related reading, see disulfiram (Antabuse), what is alcohol use disorder, naltrexone for alcohol, and Antabuse vs. naltrexone, weighed side by side.

FAQ

Is acamprosate the same as naltrexone?

No. They are both FDA-approved for alcohol use disorder, but they work differently. Naltrexone turns down the reward you get from a drink, so a drink feels less worth it. Acamprosate leaves that reward alone and instead helps steady a brain that stays restless and off-balance in the months after you stop. They tend to be considered for somewhat different situations.

Is acamprosate for withdrawal?

No — it is for staying stopped after you have already quit, not for getting through withdrawal itself. And withdrawal is not something to tough out alone: stopping suddenly after heavy daily drinking can be genuinely dangerous, so the safe move is to have a clinician help you plan it. If you do not have someone to ask, SAMHSA can help with confidential treatment referrals at 1-800-662-HELP. And if a stretch without alcohol has ever brought on shaking, sweating, confusion, or a seizure, treat that as a medical emergency — call 911 or go to an emergency room.

Can a primary-care clinician prescribe acamprosate?

Yes — you do not need a specialist. Plenty of primary-care and other licensed clinicians can discuss and prescribe medications for alcohol use disorder. If you do not have a clinician, or would rather not start with an in-person office visit, look for a care path that includes real clinical review rather than a self-serve medication menu. Whether it is the right fit is still a decision you make together.

This article is general education — not medical advice, a dosing guide, or a prescription. Any decision about medication is one to make with a licensed clinician who knows your history.

Coming soon

Want the private naltrexone update?

Join the launch list to hear first. Today, this is still educational content, not a prescription request or clinical intake.

Get the naltrexone updateNot a prescription request, not medical advice, and not available for treatment today.